Are you ready for
an FDA inspection?

Inspection readiness program in Early Phase Clinical Trials

April 11th, 2024, 4:00 PM CET

Please be informed that the number of participants is limited to 300.

WEBINAR STARTS IN

Days
Hours
Minutes
Seconds

Experience, knowledge & practice

FREE Webinar – April 11th, 2024

Are you ready for an FDA inspection?

Biokinetica’s team will share an experience on FDA Inspections, and methods how effectively support your organization to be optimally prepared for any announced or unannounced Inspection.

We will focus on Early Phase study Inspections considering the increasing number of Biologic and Biosimilar projects submitted to the FDA for review and approval.

Our Webinar will provide insights how to prepare your team, your documentation, your facilities and the logictics.

We will discuss communication with the Inspector, and behaviours of the team during the Inspection and during interviews, as well as the value of a mock audit.

The Biokinetica team will be happy to entertain any question from the audience, and be available for follow up.

A brief summary in form of a checklist will be shared upon request.

Our webinar will show you

1

How to prepare
your

TEAM

2

How to prepare
your

FACILITY

3

How to prepare
your study

DOCUMENTATION

4

How to prepare
your participating

SITES

Host & Speakers

Ronald Koening

Ronald Koning MD, NP

SPEAKER

Chief Strategic Advisor

Tomasz Kosieradzki

Tomasz Kosieradzki MD

 SPEAKER

Head of Quality Assurance

Frequently asked questions

What is the purpose of our webinar?

Our main goal is to collect vast experience and knowledge about early phase clinical trials and share it with a broad international audience.

Our seminars are dedicated to professionals with a broad range of experience and lay audience as well. Even if you have years of experience, you will find something interesting, as we would like to focus on sharing the experience of our presenters based on real-life cases.

BIOKINETICA (EPI) is a connecting point for sponsors, CROs and Investigators. Our mission is to do Phase 1 trials, but our ambition is to deliver knowledge and experience to the public and our clients.

A discussion with the presenter is foreseen after most panels – please see the agenda.

Events

Nov 2019
Nov 2021
Apr 2024
Jun 2024
Training on early drug development
Challenges in conducting phase 1 trials in pandemic time
Are you ready for the FDA?
Coming soon

To ensure the best possible experience, the website contains cookies. Please read our privacy policy.